DE
TMO icon

DV Equities’s Thermo Fisher Scientific TMO Stock Holding History

DV Equities’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$305K Buy
+526
New +$297K 0.05% 93

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

DV Equities's TMO Position: Q4 2025 in Review

DV Equities opened a new position in Thermo Fisher Scientific (TMO) in Q4 2025: 526 shares worth $305K. The stake represents 0.05% of the portfolio and ranks #93 among its holdings.

2,701 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • DV Equities held 526 shares of Thermo Fisher Scientific worth $305K as of Q4 2025.
  • Thermo Fisher Scientific was a new DV Equities position in Q4 2025.
  • Thermo Fisher Scientific made up 0.05% of DV Equities's portfolio in Q4 2025, its #93 holding.
  • 2,701 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on DV Equities's 13F filing for Q4 2025, filed 17 Feb 2026.